Scientists at Fred Hutchinson Cancer Research Center have developed a new method for counting a special class of cancer-fighting cells – called tumor-infiltrating T lymphocytes - reliably, quickly and cheaply in patients with early stage and advanced ovarian cancer. Such technology, a DNA - amplification technique, has the potential to predict treatment response, cancer recurrence and disease-free survival earlier and more effectively than any current method, according to lead researcher and cancer geneticist Jason H. Bielas, Ph.D., an associate member of the Human Biology and Public Health Sciences divisions at Fred Hutch. Read more here.
Study mentioned: Robins HS, et al. Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes. Sci Transl Med. 2013; 5(214):p. 214ra169.
No comments:
Post a Comment